About
Technology
Issues
FAQ
Links
Official Page
OP0078 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-WEEK) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.